SciELO - Scientific Electronic Library Online

 
vol.34 número4Factors related with ventilator-associated pneumonia in an intensive care unit of the colombian Orinoco river regionControversy about the use of bisphosphonates in patients with kidney disease índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Acta Medica Colombiana

versão impressa ISSN 0120-2448

Resumo

LUJAN, Mauricio et al. Myelophthisis: Old aspects, new concepts. Acta Med Colomb [online]. 2009, vol.34, n.4, pp.169-175. ISSN 0120-2448.

Background: myelophthisis is a form of bone marrow failure due to replacement of hematopoietic tissue by abnormal tissue, most commonly metastatic carcinomas. Materials and methods: this retrospective study included 89 patients (pts) with solid tumors and myelophtisis that had been treated from 1991 to 2006 in a single reference center in Bogotá. We made a detailed analysis of pts characteristics and outcomes. Results: mean age was 47.5+17.2 years, there was homogeneous gender distribution (F46/M43) and 62% patients had a PS =60%. Twenty-seven patients (30%) had breast cancer, pathology followed by primary unknown tumours (21%), rabdomiosarcoma (10%), prostate adenocarcinoma (10%), gastric carcinoma (7%) and others (22%). At the time when myelophtisis was documented 72% and 50% of patients had osseous and visceral metastasis respectively; 81 patients presented anaemia (Hb 9.8 + 1.2 gr/dl), mean platelet count was 174,000 and mean leukocyte count was 24,283 + 5,447. Forty-three patients received chemotherapy following the diagnosis of medullar infiltration, and normal leukocyte count was being seen in 40% of them after such treatment. Nine episodes of febrile neutropenia were found; median overall survival (OS) following the diagnosis of neoplasia and myelophtisis were 13.8 months and 2.2 months respectively. The factors related to lower survival rate were the presence of Hb =8.5 gr/dl (HR: 0,54, CI95% 0,32-0,95; p = 0.04), >3 metastasis sites (HR: 0,67, CI95% 0,45-0,92; p = 0.03), visceral disease (HR: 0,72, CI95% 0,66-0,89; p = 0.04) and febrile neutropenia caused by chemotherapy (HR: 0,52, CI95% 0,37-0,60; p = 0.02). Conclusions: myelophtisis is a serious condition modifying the OS of patients having solid tumours. Treatment for this subgroup should be selected bearing in mind its potential haematological toxicity.

Palavras-chave : myelophtisis; leucoerithroblastosis; bone marrow infiltration; solid tumors.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons